BRAINWeek Conference 2024 GAPS IN BRAIN HEALTH Putting Together The Pieces: Event Recap
Join us as we recap the highlights of the BRAINWeek Conference 2024!
May 16, 2024
BRAIN Waves taps into decades of medical education expertise to curate innovative brain health education, offering the latest insights, news, and clinical approaches in easily digestible formats. Our brain health education resources and partner offerings translate cutting-edge research into practical clinical strategies.
Explore our brain education resources and enhance your clinical expertise to better treat brain-related conditions while fostering a deeper understanding of holistic brain health. Your journey to clinical excellence starts here.
Stay up to date with the latest information on live events, online educational offerings, and industry news by subscribing to the BRAINWaves newsletter powered by BRAINWeek, a resource hub of brain health education to equip you to foster holistic brain health.
Clinical research has demonstrated that aging is not a uniform process and certain aspects of the nervous system have age-related vulnerabilities which cause the problems that are responsible for failures of the 4M’s of brain health:
Alzheimer’s disease is the most common cause of dementia worldwide, with the prevalence continuing to grow in part because of the aging world population. This neurodegenerative disease process is characterized classically by two hallmark pathologies:
In this lecture the broad differential diagnosis of memory loss and dementia are presented, including dementia with Lewy bodies, vascular dementia, frontotemporal dementia, progressive supranuclear palsy, corticobasal degeneration, normal pressure hydrocephalus, Creutzfeldt-Jakob disease, depression, Lyme disease, chronic traumatic encephalopathy, and others.
Join us as we recap the highlights of the BRAINWeek Conference 2024!
This Mental Health Awareness Month (beginning May 1st), it’s imperative to move beyond acknowledgment and into action. Mental disorders stand as one of the foremost causes of burden and disability worldwide. Each year, approximately 18.1% of U.S. adults, equivalent to 43.6 million individuals aged 18 years or older, grapple with mental illness. Among the wide range of
Alzheimer’s Disease: Rising Cases, Lagging Diagnoses, and Undertreatment Currently, about 6.2 million Americans aged 65 and older grapple with Alzheimer’s dementia (AD), a figure set to balloon to 13.8 million by 2060, barring medical breakthroughs to prevent, slow, or cure AD. In 2011, approximately 4.5 million individuals aged sixty-five and above were living with clinical Alzheimer’s disease.
Migraine Prevalence, Costs, and Treatment Gaps Migraines are not just a nuisance; they also pose a significant public health challenge, affecting up to 17% of women and 6% of men annually. These statistics vary globally, with North America experiencing the highest prevalence, followed by South America, Central America, Europe, Asia, and Africa. Shockingly, migraines account for
As we approach World Health Day on April 7, 2024, under the theme ‘My Health, My Right,’ it’s imperative to recognize the universal right to quality healthcare, education, and information. Brain health is central to this notion – the cornerstone of an individual’s capacity to realize their full potential over life course. As a dedicated provider, it’s
Cybin, a clinical-stage biopharmaceutical company, has received FDA Breakthrough Therapy Designation (BTD) for CYB003, a novel deuterated psilocybin analog designed to treat Major Depressive Disorder (MDD). This designation acknowledges CYB003’s potential to revolutionize depression treatment, addressing a significant unmet need affecting millions globally. In a phase 2 trial, CYB003 demonstrated positive topline results: Patients receiving
BRAINWeek
1801 N. Military Trail Suite 110
Boca Raton, Florida 33431
Copyright © 2024, BRAINWeek. All trademarks, registered or unregistered, are the property of their respective owners.
